|
1
|
McPherson K, Steel CM and Dixon JM: ABC of
breast diseases. Breast cancer-epidemiology, risk factors, and
genetics. BMJ. 321:624–628. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benson JR and Jatoi I: The global breast
cancer burden. Future Oncol. 8:697–702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anderson WF, Katki HA and Rosenberg PS:
Incidence of breast cancer in the United States: current and future
trends. J Natl Cancer Inst. 103:1397–1402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reuter S, Prasad S, Phromnoi K, Kannappan
R, Yadav VR and Aggarwal BB: Embelin suppresses osteoclastogenesis
induced by receptor activator of NF-κB ligand and tumor cells in
vitro through inhibition of the NF-κB cell signaling pathway. Mol
Cancer Res. 8:1425–1436. 2010.PubMed/NCBI
|
|
5
|
Hu R, Zhu K, Li Y, Yao K, Zhang R, Wang H,
Yang W and Liu Z: Embelin induces apoptosis through down-regulation
of XIAP in human leukemia cells. Med Oncol. 28:1584–1588. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita
Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME,
Yang D and Wang S: Discovery of embelin as a cell-permeable,
small-molecular weight inhibitor of XIAP through structure-based
computational screening of a traditional herbal medicine
three-dimensional structure database. J Med Chem. 47:2430–2440.
2004. View Article : Google Scholar
|
|
7
|
Joshi R, Kamat JP and Mukherjee T: Free
radical scavenging reactions and antioxidant activity of embelin:
biochemical and pulse radiolytic studies. Chem Biol Interact.
167:125–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sreepriya M and Bali G: Effects of
administration of Embelin and Curcumin on lipid peroxidation,
hepatic glutathione antioxidant defense and hematopoietic system
during N-nitrosodiethylamine/Phenobarbital-induced
hepatocarcinogenesis in Wistar rats. Mol Cell Biochem. 284:49–55.
2006. View Article : Google Scholar
|
|
9
|
Mahendran S, Badami S, Ravi S, Thippeswamy
BS and Veerapur VP: Synthesis and evaluation of analgesic and anti-
inflammatory activities of most active free radical scavenging
derivatives of embelin-A structure-activity relationship. Chem
Pharm Bull. 59:913–919. 2011. View Article : Google Scholar
|
|
10
|
Thippeswamy BS, Mahendran S, Biradar MI,
Raj P, Srivastava K, Badami S and Veerapur VP: Protective effect of
embelin against acetic acid induced ulcerative colitis in rats. Eur
J Pharmacol. 654:100–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Danquah M, Li F, Duke CB III, Miller DD
and Mahato RI: Micellar delivery of bicalutamide and embelin for
treating prostate cancer. Pharm Res. 26:2081–2092. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma
J, Zou B, Gu Q, Wang J, Pang R, Lan HY and Wong BC: Peroxisome
proliferator-activated receptor-gamma contributes to the inhibitory
effects of Embelin on colon carcinogenesis. Cancer Res.
69:4776–4783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aird KM, Ding X, Baras A, Wei J, Morse MA,
Clay T, Lyerly HK and Devi GR: Trastuzumab signaling in
ErbB2-overexpressing inflammatory breast cancer correlates with
X-linked inhibitor of apoptosis protein expression. Mol Cancer
Ther. 7:38–47. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mori T, Doi R, Kida A, Nagai K, Kami K,
Ito D, Toyoda E, Kawaguchi Y and Uemoto S: Effect of the XIAP
inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer
cells. J Surg Res. 142:281–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiarugi P and Giannoni E: Anoikis: a
necessary death program for anchorage-dependent cells. Biochem
Pharmacol. 76:1352–1364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allensworth JL, Aird KM, Aldrich AJ,
Batinic-Haberle I and Devi GR: XIAP inhibition and generation of
reactive oxygen species enhances TRAIL sensitivity in inflammatory
breast cancer cells. Mol Cancer Ther. 11:1518–1527. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang B, Zhang Y, Liang R, Yuan P, Du J,
Wang H and Wang L: Activation of the δ-opioid receptor inhibits
serum deprivation-induced apoptosis of human liver cells via the
activation of PKC and the mitochondrial pathway. Int J Mol Med.
28:1077–1085. 2011.
|
|
19
|
Mattson MP and Kroemer G: Mitochondria in
cell death: novel targets for neuroprotection and cardioprotection.
Trends Mol Med. 9:196–205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burlacu A: Regulation of apoptosis by
Bcl-2 family proteins. J Cell Mol Med. 7:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saito M, Korsmeyer SJ and Schlesinger PH:
BAX-dependent transport of cytochrome c reconstituted in pure
liposomes. Nat Cell Biol. 2:553–555. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nicholson DW, Ali A, Thornberry NA,
Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle
M and Lazebnik YA: Identification and inhibition of the ICE/CED-3
protease necessary for mammalian apoptosis. Nature. 376:37–43.
1995. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hyman BT and Yuan J: Apoptotic and
non-apoptotic roles of caspases in neuronal physiology and
pathophysiology. Nat Rev Neurosci. 13:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi LG, Zhang GP and Jin HM: Inhibition of
microvascular endothelial cell apoptosis by angiopoietin-1 and the
involvement of cytochrome C. Chin Med J (Engl). 119:725–730.
2006.PubMed/NCBI
|
